Cargando…
A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022
BACKGROUND: To cope with the persistence of the COVID-19 epidemic and the decrease in antibody levels following vaccination, a third dose of vaccine has been recommended in the general population. However, several vaccine regimens had been used initially for the primary vaccination course, and the h...
Autores principales: | Guibert, Nicolas, Trepat, Kylian, Pozzetto, Bruno, Josset, Laurence, Fassier, Jean-Baptiste, Allatif, Omran, Saker, Kahina, Brengel-Pesce, Karen, Walzer, Thierry, Vanhems, Philippe, Trouillet-Assant, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103547/ https://www.ncbi.nlm.nih.gov/pubmed/37052679 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.15.2200746 |
Ejemplares similares
-
Specific detection of memory T‐cells in COVID‐19 patients using standardized whole‐blood Interferon gammarelease assay
por: Mouton, William, et al.
Publicado: (2021) -
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
por: Saker, Kahina, et al.
Publicado: (2022) -
Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers
por: Saker, Kahina, et al.
Publicado: (2022) -
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays
por: Bal, Antonin, et al.
Publicado: (2021) -
Vaccination as an Equaliser? Evaluating COVID-19 Vaccine Prioritisation and Compensation
por: Günther, Christian, et al.
Publicado: (2022)